ArticleFrontiers in oncology2024

Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications.

Eziafa I Oduah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.